Quick access :

Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan

23/05/2019

Mr Chan, former CEO of Magellan, brings over 35 years of experience as both a director and operational executive in the technology and life sciences space.

CEVA SANTE ANIMALE AND IDT BIOLOGIKA GMBH ANNOUNCE AGREEMENT

17/05/2019

CEVA to acquire the IDT Animal Health business, expanding its global vaccine portfolio and boosting swine innovation.

SGH Healthcaring - An original primary packaging range for nutraceuticals

07/05/2019

Having recently acquired Eskiss Packaging, the group now offers a wide range of primary packagaing for the food supplement sector.

Ivantis announces groundbreaking 3 year results from FDA clinical trial

02/05/2019

First device in Minimally Invasive Glaucoma Surgical (MIGS) category to demonstrate significant long-term reduction of severe major surgeries for glaucoma patients. This is the first study of any kind showing a MIGS device achieving a statistically significant reduction in secondary incisional surgery; over 70% of patients remain free of medications.

Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam

01/05/2019

Favorable pharmacokinetic, safety, and tolerability results support continued development of Xeris' diazepam. Phase 2 study to be initiated in 2H2019.

Inscripta Appoints Ron McGrath as Chief Financial Officer

30/04/2019

Mr. McGrath has held leadership and financial roles for over 25 years in the biotechnology and information technology industries.

Mérieux Equity Partners teams up with ICG to acquire leading Italian generic company, DOC Generici

08/04/2019

DOC Generici is Italy’s largest independent generic pharmaceutical company.

Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M

04/04/2019

Continued support of existing investors will fund commercialization efforts, product launch later this year.

Merieux Equity Partners to enter in exclusive negotiations for the sale of their stake in Amplitude Laser Group to L-GAM

28/03/2019

Amplitude Laser Group has transformed itself into a global leader with a truly international footprint.